{
    "2020-09-22": [
        [
            {
                "time": "",
                "original_text": "贝达药业(300558.SZ)：股东凯铭投资解除质押256.3万股",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "凯铭投资",
                        "解除质押",
                        "256.3万股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业(300558.SZ)：埃克替尼术后辅助治疗的上市许可申请获得受理",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "埃克替尼",
                        "术后辅助治疗",
                        "上市许可申请",
                        "受理"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业(300558.SZ)控股股东凯铭投资解质256.3万股",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "凯铭投资",
                        "解质",
                        "256.3万股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}